Abstract
In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly different (P less than 0.05). The cancers detected by screening were predominantly 'early stage', with 16% noninvasive (PTIS) and 42% invasive stage I (pT1 node negative), whereas cancers were frequently 'late stage' (more than pT2) and inoperable in nonattenders (44%) and controls (36%). Grouped according to customary size ranges of invasive cancers, the proportion of cases lymph node positive differed in those screen detected compared with controls, but the benefit in favour of screen detection was not constant. In comparisons of cancers detected at prevalence and incidence screens, as a test of conformity with screening theory, no significant differences were apparent according to size and lymph node status, yet the characteristics of histological type of cancer discriminated significantly (P less than 0.05). When these same histological characteristics were used to compare survival, the capacity to separate invasive cancers into two groups having good and poor survival probabilities was evident, with a significant improvement for the screen detected poor survival group compared with controls (P less than 0.05).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anderson, T., Lamb, J., Donnan, P. et al. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer 64, 108–113 (1991). https://doi.org/10.1038/bjc.1991.251
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.251
This article is cited by
-
A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women
Breast Cancer (2017)
-
Reduction in rate of node metastases with breast screening: consistency of association with tumor size
Breast Cancer Research and Treatment (2013)
-
Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes
Breast Cancer Research and Treatment (2012)
-
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
British Journal of Cancer (2010)
-
Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al
British Journal of Cancer (2005)